A therapeutic evaluation to the pathogeneses of deep keratitis of obscure origin.
D000287:Administration, Topical; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001205:Ascorbic Acid / Q000627:therapeutic use; D002701:Chloramphenicol / Q000627:therapeutic use; D003348:Cortisone / Q000627:therapeutic use; D003907:Dexamethasone / Q000627:therapeutic use; D006801:Humans; D007634:Keratitis / Q000188:drug therapy* / Q000209:etiology*; D007635:Keratitis, Dendritic / Q000209:etiology; D009883:Ophthalmic Solutions; D011239:Prednisolone; D013307:Streptomycin / Q000627:therapeutic use; D014605:Uveitis / Q000150:complications
D000893:Anti-Inflammatory Agents; D009883:Ophthalmic Solutions; D002701:Chloramphenicol; D003907:Dexamethasone; D011239:Prednisolone; D001205:Ascorbic Acid; D003348:Cortisone; D013307:Streptomycin